|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | -99.50% |
| 24-05-20 | Clever Leaves Holdings Inc.(NasdaqCM:CLVR) dropped from S&P TMI Index | CI |
| 24-05-16 | Clever Leaves Shares Rise as Brazil Investment Fund Acquires 8.5% Stake Before Nasdaq Delisting | MT |
| Market Cap | 350 303.73 279.97 262.34 490.15 33.51K 500.36 3.34K 1.29K 16.15K 1.31K 1.29K 56.17K | P/E Ratio 2022 |
-0.18x | P/E Ratio 2023 | -0.18x |
|---|---|---|---|---|---|
| Enterprise Value | -4.74M -4.12M -3.79M -3.56M -6.64M -454M -6.78M -45.26M -17.52M -219M -17.81M -17.42M -761M | EV / Sales 2022 |
445,103x | EV / Sales 2023 | -62,512x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0.5 | |
| 3 years | 0 | 8.1 | |
| 5 years | 0 | 372 | |
| 10 years | 0 | 583.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrés Fajardo
CEO | Chief Executive Officer | 48 | 2022-03-24 |
Henry Hague
DFI | Director of Finance/CFO | 54 | 2021-02-21 |
Escobar Gustavo
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Julien
BRD | Director/Board Member | 56 | 2020-12-17 |
Andrés Fajardo
BRD | Director/Board Member | 48 | 2020-11-30 |
| Director/Board Member | 70 | 2020-12-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-05-15 | Other | 322,234 | 18.3631% | |||
| 24-03-07 | Sell | Chief Financial Officer | 170 | 0.0097% | ||
| 24-02-26 | Sell | Chief Financial Officer | 411 | 0.0236% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 1 | ||
| +0.82% | +4.01% | -11.30% | -3.81% | 13.31B | ||
| -1.10% | -2.21% | -35.37% | -56.82% | 4.92B | ||
| -0.22% | +2.94% | -9.20% | -2.82% | 4.74B | ||
| -1.86% | -5.35% | +8.38% | -21.79% | 3.78B | ||
| -1.61% | +0.40% | +2.70% | -43.28% | 3.76B | ||
| -2.69% | -4.14% | -5.21% | -10.76% | 3.59B | ||
| -0.91% | +1.00% | -13.63% | -5.90% | 3.13B | ||
| -1.50% | -2.43% | -13.60% | -32.08% | 2.25B | ||
| -6.14% | -3.41% | -15.13% | +24.40% | 1.72B | ||
| Average | -1.52% | -1.85% | -10.26% | -16.98% | 4.12B | |
| Weighted average by Cap. | -0.85% | -0.51% | -10.78% | -16.41% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 17.8 15.45 14.24 13.34 24.93 1.7K 25.45 169.85 65.76 821.56 66.82 65.38 2.86K | 17.42 15.11 13.93 13.05 24.39 1.67K 24.9 166.2 64.35 803.88 65.38 63.97 2.8K |
| Net income | -66.17M -57.42M -52.93M -49.59M -92.66M -6.34B -94.59M -631M -244M -3.05B -248M -243M -10.62B | -17.9M -15.53M -14.32M -13.42M -25.07M -1.71B -25.59M -171M -66.13M -826M -67.19M -65.74M -2.87B |
| Net Debt | -8.59M -7.46M -6.87M -6.44M -12.03M -823M -12.28M -82M -31.75M -397M -32.26M -31.56M -1.38B | -4.74M -4.12M -3.79M -3.56M -6.64M -454M -6.78M -45.27M -17.53M -219M -17.81M -17.43M -761M |
Employees
296
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 0.000001 $ | 0.00% | 270 |
- Stock Market
- Stocks
- CLVR Stock
Select your edition
All financial news and data tailored to specific country editions
















